CN Patent

CN117298115A — CDKs抑制剂的药物组合物及制备方法

Assigned to Xuanzhu Biopharmaceutical Co Ltd · Expires 2023-12-29 · 2y expired

What this patent protects

本发明属于医药技术领域，具体涉及一种CDKs抑制剂式(I)化合物的药物组合物，所述药物组合物的制备方法以及在制备用于治疗癌症的药物中的用途。本发明所提供的药物组合物性能良好、性质稳定，生产工艺稳健，质量稳定可控，可重复性强，可满足工业化生产的需要，

USPTO Abstract

本发明属于医药技术领域，具体涉及一种CDKs抑制剂式(I)化合物的药物组合物，所述药物组合物的制备方法以及在制备用于治疗癌症的药物中的用途。本发明所提供的药物组合物性能良好、性质稳定，生产工艺稳健，质量稳定可控，可重复性强，可满足工业化生产的需要，

Drugs covered by this patent

Patent Metadata

Patent number
CN117298115A
Jurisdiction
CN
Classification
—
Expires
2023-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Xuanzhu Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.